跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 660 条关于
“TransCon aVEGF”
全部
660
临床试验
484
药物
85
机构
8
资讯
83
8个月前
Ascendis Pharma Reports Strong 2025 Performance with €720M Revenue and Advances TransCon Pipeline
上个月
Eyconis Initiates First-in-Human Trial of Long-Acting Anti-VEGF Therapy EYC-0305 in Treatment-Naïve Wet AMD
去年
TransCon hGH Meets Primary Endpoint in Turner Syndrome Trial
2年前
TransCon CNP Demonstrates Superior Growth in Achondroplasia Trial
去年
TransCon PTH Shows Sustained 4-Year Efficacy in Hypoparathyroidism Patients
2年前
TransCon CNP Demonstrates Superior Growth Velocity in Achondroplasia Trial
去年
FDA Accepts Ascendis Pharma's TransCon hGH Application for Adult Growth Hormone Deficiency
11个月前
Ascendis Pharma Submits European Marketing Application for TransCon CNP in Achondroplasia Treatment
10个月前
TransCon PTH Shows Sustained Kidney Function Improvements in 3-Year Hypoparathyroidism Study
2个月前
Ascendis Pharma Reports Positive TransCon CNP Clinical Data Amid Revenue Growth to $720 Million
第 1 页,共 9 页
上一页
下一页